Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezafibrate + UDCA in PBC patients with inadequate response
NCT04751188Phase 3Unknown
- Sponsor
- Instituto Mexicano del Seguro Social
- Start
- Oct 2020
- Primary completion
- Jun 2021
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bezafibrate in primary biliary cholangitis (PBC), sponsored by Instituto Mexicano del Seguro Social. Status: unknown.
02
Drugs
bezafibrate
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT04751188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04751188.